Status:
COMPLETED
Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.
Eligibility Criteria
Inclusion
- Patient over the age of 18;
- Diagnostic COVID-19 by RT-PCR;
- Hospitalisation in resuscitation for the management of complications related to COVID-19
- Implanted ECMO-VV during hospitalisation;
- Patient agreeing to participate in the study
Exclusion
- Sujet under guardianship or trusteeship
- Sujet under safeguard of justice
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04343404
Start Date
April 1 2020
End Date
April 15 2020
Last Update
June 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091